Seven Basque biotech companies will attend the most important event in this industrial sector, to be held in San Francisco between 6 and 9 June.
Seven Basque companies in the biotechnology sector will participate next week, between 6 and 9 June, at the BIO International Convention 2016, the most important event for the biotechnology industry, held in the U.S. city of San Francisco, California. These companies will attend in the delegation and on the stand organised by the Basque business agency, SPRI, part of the Basque Government Department of Economic Development and Competitiveness.
The BIO International Convention 2016 brings together more than 1,700 exhibitors, including leading biotechnology companies, the world’s major pharmaceutical companies and more than 300 organisations such as academic institutions, research centres and government agencies.
Like at previous editions, the Basque delegation will be located on the booth organised by ICEX and distributed into three areas: two of them represent the bioregions of the Basque Country (Biobasque) and of Catalonia (Biocat), while the third (SpainBio) is intended to house companies from other regions, as well as state-level institutions.
The seven Basque companies attending this important event are Artinvet, BBD Biophenix-Biobide, Geroa Diagnostics, Histocell, Innoprot, Oncomatryx and Stemtek Therapeutics. Also represented in the SPRI group are the Enterprise Europe Network (EEN) and the BIC business incubators of Araba, Bizkaia and Gipuzkoa. EEN, one of the key support instruments for SMEs on the continent, brings together nearly 600 organisations across Europe, of which SPRI is part of one. The Basque EEN Consortium also consists of the Chambers of Commerce of Bilbao, Gipuzkoa and Álava, Innobasque and Beaz. The BICs (Business Innovation Centres), formerly CEIs (Centros de Empresas e Innovación), are support services for entrepreneurs and companies, aimed at promoting innovative and/or technology-based business initiatives and fostering their development.
The biotechnology sector in the Basque Country consists of more than 70 companies and a score of entities involved in research, including universities, research centres, technology centres and hospitals. This sector, of growing importance in the Basque economy, currently provides employment for more than 2,000 people, invoices around 304 million euros a year and has been identified as one of the priority areas for the Basque Government in its smart specialisation strategy, RIS3.
Some thirty of these companies make up the Basque Biocluster, an association created in October 2010 to coordinate and defend the interests of its members, in collaboration with public administrations and other organisations in the life science sector, as well as to contribute to the development, growth and internationalisation of its members and the bioscience sector In the Autonomous Community of the Basque Country.
The BIO International Convention offers a comprehensive programme covering networking events, company presentations, an exhibition area – considered the largest in the world among events in this sector-, and lectures on new trends in biotechnology and all the technological innovations, among other activities.
One of the keys to the success of this event lies in the exceptional opportunity provided for participants to use the partnering system operating during the Convention, during which Basque companies will hold more than 150 meetings in search of partnerships with major players in the global biotech world.